Literature DB >> 19528479

(-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.

Yi-Wen Huang1, Li-Shu Wang, Michael K Dowd, Peter J Wan, Young C Lin.   

Abstract

BACKGROUND: Acquisition of metastatic ability by prostatic cancer cells is the most lethal aspect of prostatic cancer progression. (-)-Gossypol, a polyphenolic compound present in cottonseeds, possesses anti-proliferative and proapoptotic effects in various cancer cells.
MATERIALS AND METHODS: In this study, the differences between MAT-LyLu, rat prostate cancer cells, with a novel isolated subline from metastasized tumors in the lungs of MAT-LyLu-bearing Copenhagen rats (MLL cells) were compared with respect to cell growth and invasion. The effects of (-)-gossypol on cell viability, colony formation, invasive ability and cell migration in MAT-LyLu and MLL cells were also evaluated.
RESULTS: Results showed that MLL cells displayed higher growth ability, colony formation and aggressive penetration than those of MAT-LyLu cells. MLL cells possess lower protein expression of Bcl-xL and nm23-H1 than those of MAT-LyLu cells, implying differences in invasive ability. Moreover, (-)-gossypol treatment induced a dose-dependent inhibition of invasive activity and cell viability and reduced Bcl-2 and Bcl-xL proteins but induced nm23-H1 protein in both cell lines.
CONCLUSION: These findings illustrated that (-)-gossypol reduced in vitro invasion of both the parental MAT-LyLu cells and the isolated MLL cells, suggesting that (-)-gossypol might serve as a chemotherapeutic and/or chemopreventive agent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528479

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling.

Authors:  Jiahua Jiang; Veronika Slivova; Andrej Jedinak; Daniel Sliva
Journal:  Clin Exp Metastasis       Date:  2011-12-14       Impact factor: 5.150

2.  (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.

Authors:  Xiufeng Pang; Yuanyuan Wu; Yougen Wu; Binbin Lu; Jing Chen; Jieqiong Wang; Zhengfang Yi; Weijing Qu; Mingyao Liu
Journal:  Mol Cancer Ther       Date:  2011-03-03       Impact factor: 6.261

Review 3.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

Review 4.  Small-molecule inhibitors reveal a new function for Bcl-2 as a proangiogenic signaling molecule.

Authors:  Benjamin D Zeitlin; Jacques E Nör
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

5.  Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.

Authors:  Xian-Qing Zhang; Xiao-Feng Huang; Shi-Jie Mu; Qun-Xing An; Ai-Jun Xia; Rui Chen; Dao-Cheng Wu
Journal:  Asian J Androl       Date:  2010-01-18       Impact factor: 3.285

6.  Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway.

Authors:  Luyuan Zhang; Sinan Sun; Yumin Wang; Yongzhen Mo; Fang Xiong; Shanshan Zhang; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Hao Chen; Can Guo
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

7.  Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models.

Authors:  M A Jarzabek; V Amberger-Murphy; J J Callanan; C Gao; A M Zagozdzon; L Shiels; J Wang; K L Ligon; B E Rich; P Dicker; W M Gallagher; J H M Prehn; A T Byrne
Journal:  Br J Cancer       Date:  2014-11-06       Impact factor: 7.640

8.  Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.

Authors:  Tao Ren; Jinlu Shan; Yi Qing; Chengyuan Qian; Qing Li; Guoshou Lu; Mengxia Li; Chongyi Li; Yu Peng; Hao Luo; Shiheng Zhang; Weiwei Zhang; Dong Wang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

9.  Isolation of Cottonseed Extracts That Affect Human Cancer Cell Growth.

Authors:  Heping Cao; Kandan Sethumadhavan; John M Bland
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

10.  Gossypol decreased cell viability and down-regulated the expression of a number of genes in human colon cancer cells.

Authors:  Heping Cao; Kandan Sethumadhavan; Fangping Cao; Thomas T Y Wang
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.